SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay

Trial ID or NCT#

NCT02730468

Status

not recruiting iconNOT RECRUITING

Purpose

The purpose of this study is to evaluate the performance of the Karius Infectious Diseases Plasma Sequencing Assay in patients who present to the emergency room with sepsis.

Official Title

SEP-SEQ Trial - Determining the Etiology of Sepsis Using an Infectious Disease Diagnostic Sequencing Assay

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. 1. 18 years or older2. Meet 2 of 4 sepsis criteria
  2. 1. Temperature \> 38C or \< 36C 2. Heart rate \> 90 bpm 3. Respiratory rate \>20 or PaCO2 \<32mmHg 4. WBC \>12000/µL or \< 4000/µL or \> 10% bands
Exclusion Criteria:
  1. 1. Inability to understand instructions and comply with study-related procedures2. Any condition that in the opinion of the treating physician will prevent the subject from completing the study.
View All Criteria
Show Less

Investigator(s)

Samuel Yang, MD, FACEP
Samuel Yang, MD, FACEP
Emergency medicine doctor
Professor of Emergency Medicine (Adult Clinical/Academic)

View on ClinicalTrials.gov